SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-033593
Filing Date
2017-05-18
Accepted
2017-05-18 16:36:50
Documents
1
Period of Report
2017-05-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6842
  Complete submission text file 0001209191-17-033593.txt   9017
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Reporting) CIK: 0001114448 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37926 | Film No.: 17855315
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000
Business Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000 41-61-324-6210
Novartis Bioventures Ltd (Reporting) CIK: 0001297709 (see all company filings)

State of Incorp.: D0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37926 | Film No.: 17855316

Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Issuer) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations